USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Saluda Medical Pty Ltd

USPTO PatentsView assignee record - 72 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

RSS updates for this company

The verdict

According to USPTO PatentsView, Saluda ranks #4,837 of 49,997 tracked US assignees by granted-patent volume, with 72 patents across 18 technology areas.

#4,837
of 49,997 US assignees by volume
Top 9%
by Innovation Score (53.7/100)
19.4
avg claims per patent
+188%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4837 · Foreign Corporation #4,837 · 72 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 72 grants
  • TOP-DECILE #4,837/49,997
  • PHOTO-FINISH Shenzhen Guanke
  • CPC-FOCUS A61N · 18 areas
  • INNOV-PAR 53.7/100
  • CLAIMS-RICH 19.4 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +188% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Shenzhen Guanke Technologies Co., Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Saluda

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Saluda's Innovation Score is 53.7/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Saluda's grants concentrate

Saluda Medical Pty Ltd is a focused PatentsView assignee: 18 CPC subclasses with 98.6% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2022 (15 grants) versus a trough of 2 in 2017. By volume, Saluda sits between Shenzhen Guanke Technologies Co., Ltd and THE University OF Liverpool.

Saluda's three-year grant acceleration

Saluda Medical Pty Ltd shows 33 grants in 2022–2024 against only 18 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Saluda's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Saluda holds 72 patents at rank #4,842, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Saluda

By rank, the assignees closest to #4,842 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Saluda's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Saluda, neither rank-band nor same-CPC leaders (those blocks stay above).

Saluda's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 9% higher than 91% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 20152016201720182019202020212022202320242025 10
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Saluda Medical Pty Ltd patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 5.6%
2016 3 4.2%
2017 2 2.8%
2018 2 2.8%
2019 5 6.9%
2020 5 6.9%
2021 8 11.1%
2022 15 20.8%
2023 5 6.9%
2024 13 18.1%
2025partial year 10 13.9%

Which technologies does Saluda Medical Pty Ltd patent most?

Top 15 of 18 technology areas

Where it ranks

Overall rank by patents

#4,837

of 49,997 tracked assignees

Innovation Score

53.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Saluda Medical Pty Ltd's patent record in context - here's where to go next.

  • Saluda Medical Pty Ltd's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 98.6% of its portfolio - see every assignee active in that class. Explore A61N
  • Ranked #4,837 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Saluda Medical Pty Ltd against Shenzhen Guanke Technologies Co., Ltd, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 53.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.